BioScale Inc., a Cambridge, MA-based life science company that develops, manufactures and promotes an innovative protein analytics technology, has secured $25m in its recent funding round.The round was led by new investor Morningside Venture, with participation from existing venture partners New Science Ventures, WFD Ventures, F2 Ventures, and other individual investors.
This funding will enable the company to expand manufacturing operations and bring the ViBE protein analytics systems, which enable ultra-sensitive detection and quantitation of proteins in complex samples used in research, clinical, bioprocessing, patient point-of-care and personalized medicine applications, into the market.
FinSMEs
14/06/2010